| Literature DB >> 34922447 |
Emily McBride1, Hiromi Mase2, Robert S Kerrison3,4, Laura A V Marlow5, Jo Waller5.
Abstract
BACKGROUND: Systematic reviews have identified effective strategies for increasing postal response rates to questionnaires; however, most studies have isolated single techniques, testing the effect of each one individually. Despite providing insight into explanatory mechanisms, this approach lacks ecological validity, given that multiple techniques are often combined in routine practice.Entities:
Keywords: Behavioural science; Methodology; Postal response; RCT; Recruitment; Trials
Mesh:
Year: 2021 PMID: 34922447 PMCID: PMC8684081 DOI: 10.1186/s12874-021-01476-7
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.615
Fig. 1Cover letter used for the intervention group
Summary of techniques used in the intervention letter
| University sponsorship as the dominant letterhead | Large University College London (UCL) logo placed at the top of the letter, with National Institute for Health Research (NIHR) logo placed at the bottom right. | Systematic review evidence [ |
| Salient and attractive letterhead to increase likelihood of attention and relevance | Coloured letterhead used (blue logo) | Salience (MINDSPACE) [ |
| Authoritative messenger to convey importance and obligation | “I am the Co-Director of the Cancer Screening Group” | Messenger (MINDSPACE) [ |
| Emphasising importance to elicit a sense of duty and personal value | “important research study “ “Your involvement is really valuable” | Ego (MINDSPACE) [ |
| Referring to emotion to elicit personal connection | “how your test result has made you feel” | Affect (MINDSPACE) [ |
| Conveying social norms by referencing the majority target group | “most women find…rewarding.” “result letters better for other women” | Norms (MINDSPACE) [ |
| Language to convey personalisation | “I am interested in your particular test result” “I’d like to hear your views” “particularly interested in hearing from you” | Systematic review evidence [ |
| Perception of exclusivity and possible sanction (i.e., missing out) | “I am only inviting a select number...” | Ego and Incentive (MINDSPACE) [ |
| Salience and visual breaking | Coloured subheadings (“Your role” and “Optional interview”) to break up paragraphs | Salience (MINDSPACE) [ |
| Perceived sanction in bold to elicit loss-aversion | “You have three weeks...to take part” | Incentives (MINDSPACE) [ |
| Minimise short-term costs (e.g., low effort) and emphasise gains | “easy and quick” “enjoyable and rewarding” “You just need to fill in… the short questionnaire” | Incentives (MINDSPACE) [ |
| Assurance of confidentiality of survey answers | “your answers will be kept strictly confidential” | Systematic review evidence [ |
| Coloured written signature | A signature using bright blue ink at the end of the letter | Systematic review evidence [ |
Note: MINDSPACE refers to a behavioural science framework within the MINDSPACE Report [22]
Fig. 2Cover letter used for the control group
Demographic characteristics for the whole sample (overall and by intervention and control group) (N = 2702)
| Variable | Control | Intervention | Total |
|---|---|---|---|
| 1349 (49.9%) | 1353 (50.1%) | 2702 (100%) | |
| Mean (SD) | 37.4 (10.8) | 37.6 (11.1) | 37.5 (11.0) |
| Missing [n (%)] | 1 (0.074%) | 0 (0%) | 1 (< 0.001%) |
| Mean (SD) | 28.2 (18.2) | 26.5 (16.5) | 27.3 (17.4) |
| Missing [n (%)] | 67 (5.0%) | 85 (6.3%) | 152 (5.6%) |
| Quintile 1 (most deprived) | 435 (33.9%) | 374 (29.5%) | 808 (31.7%) |
| Quintile 2 | 279 (21.8%) | 344 (27.2%) | 623 (24.5%) |
| Quintile 3 | 259 (20.2%) | 236 (18.6%) | 495 (19.4%) |
| Quintile 4 | 178 (13.9%) | 173 (13.7%) | 351 (13.8%) |
| Quintile 5 (least deprived) | 131 (10.2%) | 141 (11.1%) | 271 (10.6%) |
| Manchester | 1043 (77.3%) | 1047 (77.4%) | 2090 (77.4%) |
| London | 306 (22.7%) | 306 (22.6%) | 612 (22.6%) |
| 1st HPV+/normal cytology | 1103 (50.1%) | 1099 (49.9%) | 2202 (81.5%) |
| 2nd/3rd consecutive HPV+/normal cytology | 246 (49.2%) | 254 (50.8%) | 500 (18.5%) |
Note. SD standard deviation, N number of participants, %: percentage
Cervical screening test result was dichotomised to receiving a 1st HPV+/normal cytology test result vs. a 2nd or 3rd consecutive HPV+/normal cytology test result
Fig. 3Flow diagram of participants approached and responders vs. non-responders
Demographic characteristics for responders and non-responders
| Responders (N = 646) | Non-Responders (N = 2056) | |
|---|---|---|
| Control | 289 (44.7%) | 1060 (51.6%) |
| Intervention | 357 (55.3%) | 996 (48.4%) |
| Mean (SD) | 38.3 (11.9) | 37.3 (10.7) |
| Missing [n (%)] | 0 (0%) | 1 (0.0005%) |
| Mean (SD) | 25.7 (16.0) | 27.9 (17.7) |
| Missing [n (%)] | 39 (6.0%) | 113 (5.5%) |
| Quintile 1 (most deprived) | 156 (25.7%) | 653 (33.6%) |
| Quintile 2 | 176 (29.0%) | 447 (23.0%) |
| Quintile 3 | 128 (21.1%) | 367 (18.9%) |
| Quintile 4 | 88 (14.5%) | 263 (13.5%) |
| Quintile 5 (least deprived) | 59 (9.7%) | 213 (10.9%) |
| Manchester | 513 (79.4%) | 1577 (76.7%) |
| London | 133 (20.6%) | 479 (23.3%) |
| 1st HPV+/normal cytology | 505 (78.2) | 1697 (82.5%) |
| 2nd/3rd HPV+/normal cytology | 141 (21.8%) | 359 (17.5%) |
Note: SD standard deviation, N number of participants, %: percentage
Univariate and multivariate regression results for survey response (yes) in the intervention vs. control and across demographics
| Variable | Response (yes) | Unadjusted OR | Adjusted ORa | ||
|---|---|---|---|---|---|
| Control | 289 (21.42%) | – | 0.003 | – | 0.004 |
| Intervention | 357 (26.39%) | 1.32 (1.10–1.57) | 1.30 (1.09–1.55) | ||
| Age | – | 1.01 (1.00–1.02) | 0.047 | 1.01 (1.00–1.02) | 0.082 |
| IMD score | – | 0.99 (0.99–1.00) | 0.011 | 0.99 (0.99–1.00) | 0.017 |
| Manchester | 513 (24.55%) | – | 0.152 | – | 0.259 |
| London | 133 (21.73%) | 0.85 (0.69–1.06) | 0.88 (0.71–1.10) | ||
| Test result (1) | 505 (22.93%) | – | 0.013 | – | 0.024 |
| Test result (2 + 3) | 141 (28.2%) | 1.32 (1.06–1.64) | 1.29 (1.04–1.61) | ||
Note: Test result (1): 1st HPV+/normal cytology, Test result (2 + 3): 2nd or 3rd HPV+/normal cytology, OR: odds ratio, CI: confidence interval, %: percentage
aAdjusted for IMD score, age, NHS site, and test result